SHANGHAI, June 22 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Felix Hsu has been appointed Senior Vice President of WuXi AppTec U.S.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

Prior to joining WuXi, Mr. Hsu worked at Medtronic for 14 years in positions of increasing responsibility. He has broad experience as a product manager and business leader, serving as Director of Heart Valve Worldwide Marketing; Vice President of Business Excellence; Vice President of Cardiac Surgery for Asia Pacific, based in Hong Kong; and Vice President of Supply Chain Integration based in Minneapolis. Prior to working at Medtronic, he served in product management, sales management, and strategic planning roles at Abbott Laboratories and as a business manager at Sabratek. In these roles, he was successful in driving revenue growth through effective product management and in implementing strategies to improve operational excellence and reduce costs.

In his new role, Mr. Hsu will be responsible for WuXi's U.S. business. A significant portion of U.S. revenues are derived from serving the medical device industry, where Mr. Hsu has extensive experience. He will report to Edward Hu, Chief Operating Officer, acting Chief Financial Officer, and current head of U.S. operations.

"I am very pleased to welcome Felix on board as we continue to strengthen our U.S. management team," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "Our U.S. operations offer a range of testing services critical to the successful development and regulatory approval of new biologics and medical devices. We expect our U.S. business will grow under Felix's leadership."

Mr. Hsu received a bachelor's degree in Electrical Engineering from General Motors Institute and an MBA from the University of Michigan.

    For more information, please contact:

     Ronald Aldridge
     Director of Investor Relations
     WuXi PharmaTech (Cayman) Inc.
     Tel:   +1-201-585-2048
     Email: Ron_Aldridge@wuxiapptec.com

     Web: http://www.wuxiapptec.com

SOURCE WuXi PharmaTech (Cayman) Inc.

Back to top

RELATED LINKS
http://www.wuxiapptec.com